keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 89.00 | |
2 mg | In stock | $ 133.00 | |
5 mg | In stock | $ 247.00 | |
10 mg | In stock | $ 397.00 | |
25 mg | In stock | $ 652.00 | |
50 mg | In stock | $ 913.00 | |
100 mg | In stock | $ 1,230.00 |
Description | Sincalide (CCK-8) is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas. It is the 8-amino acid C-terminal fragment of cholecystokinin. |
Synonyms | SQ19844, CCK-8, Cholecystokinin octapeptide |
Molecular Weight | 1143.27 |
Formula | C49H62N10O16S3 |
CAS No. | 25126-32-3 |
keep away from moisture
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: < 0.1 mg/mL (insoluble)
DMF: 50 mg/mL (43.73 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sincalide 25126-32-3 Others PI3K/Akt cardiovascular hormone Inhibitor PI3K CCK8 Akt SQ-19844 Protein kinase B Apoptosis inflammation CCK Cholecystokinin Receptor CK‐8 SQ19844 SQ 19844 PKB CCK-8 postevacuation cholecystography Cholecystokinin octapeptide CCK Receptor inhibit CCK 8 Phosphoinositide 3-kinase inhibitor